JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2023. Vol. 68. № 2
DOI: 10.33266/1024-6177-2023-68-2-16-20
Yu.B. Deshevoi, T.A. Nasonova, O.A. Dobrynina, V.G. Lebedev,
T.A. Astrelina, A.S. Samoylov
The Effect of Drugs for Normalize Blood Supply and Trophism of Irradiated Tissues, as well as a Broad-Spectrum Antibiotic on the Course of Severe Local Radiation Injuries in Rats
A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: Yu.B. Deshevoi, e-mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To study in the experiment the therapeutic efficacy of drugs that normalize blood supply and trophism of irradiated tissues, as well as a complex broad-spectrum antibiotic, for the course of severe local radiation lesions to justify the clinical use of these drugs in this pathology.
Material and methods: Wistar-Kyoto inbred rats were exposed to local X-rays in the ilio-lumbar region of the back at a dose of 110 Gy (tube voltage 30 kV, current 6.1 mA, Al filter 0.1 mm thick), at a dose rate of 20.1 Gy / min. Irradiation field area was 8.5 cm2. Radiation exposure caused the formation of long-term (up to 3.5–4 months) non-healing radiation ulcers of the skin without a critical radiation load on the underlying tissues. For the treatment of radiation lesions, an antibiotic was used – levotetrasulfin forte, as well as drugs that affect the blood supply and trophism of irradiated tissues – pentoxifylline and detralex. The drugs were administered daily both in isolation from each other and together during the period (from the 21st to the 42nd or from the 28th to the 48th day after irradiation), when the radiation ulcer formed and its gradual healing began. The everity of radiation skin lesions and the effects of therapy were assessed in dynamics by clinical manifestations and using planimetry.
Results: It was found that the separate use of drugs in the treatment of severe local radiation lesions was not very effective. However, with the combined administration of drugs, a noticeable increase in the rate of healing of radiation ulcers was revealed. Thus, it was shown that with the joint administration of pentoxifylline (intraperitoneal, 50.0 mg / kg), detralex (75.0 mg / kg, per os) and levotetrasulfin forte (intraperitoneal, 0.1 ml / kg), the area of radiation ulcers in treated animals in the period from 98 to 126 days after irradiation was 26–80 % less compared to irradiated controls.
Conclusion: The experiments show the possibility of successful use of a complex antibiotic in combination with drugs that improve blood supply and trophism of irradiated tissues, in the treatment of severe local radiation lesions.
Keywords: local irradiation, radiation ulcer of the skin, drug therapy, antibiotic, pentoxifylline, detralex, rats
For citation: Deshevoi YuB, Nasonova TA, Dobrynina OA, Lebedev VG, Astrelina TA, Samoylov AS. The Effect of Drugs for Normalize Blood Supply and Trophism of Irradiated Tissues, as well as a Broad-Spectrum Antibiotic on the Course of Severe Local Radiation Injuries in Rats. Medical Radiology and Radiation Safety. 2023;68(2):16–20. (In Russian). DOI: 10.33266/1024-6177-2023-68-2-16-20
References
1.Radiatsionnaya Meditsina = Radiation Medicine. A Guide for Medical Researchers and Health Care Organizers. Ed. Ilin L.A. Moscow, Izdat Publ., 2001. V.2. 432 p. (In Russ.).
2.Nadezhina N.M., Galstyan I.A. Lecheniye Mestnykh Luchevykh Porazheniy = Treatment of Local Radiation Lesions. Ed. Kotenko R.V., Bushmanov A.,Yu. Moscow, A.I. Burnasyan FMBC Publ., 2013. 99 p. (In Russ.).
3.Afrikanova L.A. Ostraya Luchevaya Travma Kozhi = Acute Radiation Trauma of the Skin. Moscow, Meditsina Publ.,1975. 192 p. (In Russ.).
4.Vorobyev Ye.I., Stepanov R.P. Ioniziruyushcheye Izlucheniye i Krovenosnyye Sosudy = Ionizing Radiation and Blood Vessels. Moscow, Energoatomizdat Publ., 1985. 296 p. (In Russ.).
5.Satyamitra M.M., DiCarlo A.L. Understanding the Pathophysiology and Challenges of Development o of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of NIAID Workshop, August 20, 2015. Radiation Research. 2016;186;2:99-111.
6.Kolev M., Donchev N., Borov M. Experimental Research on the Toxicity of Pharmapentoxifylline. Exp. Med. Morhpol. 1990;29;4:57-61.
7.Product Monograph. PrTRENTAL®. ATC Code: C04AD03. Sanofi-Aventis Canada Inc, 2011. 21 p.
8.Bogachev V.Yu., Boldin B.V., Turkin P.Yu. Comparative Effectiveness of Various Methods of Treatment of Chronic Venous Edema in Real Clinical Practice. Angiologiya i Sosudistaya Khirurgiya = Angiology and Vascular Surgery. 2021;21;3:77-83 (In Russ.).
9.Man M.Q., Yang B., Elias P.M. Benefits of Hesperidin for Cutaneous Functions. Hindawi Evidence-Based Complementary and Alternative Medicine. 2019;2019;2676307:19. URL: https://doi.org/10.1155/2019/2676307.
10.Gunik A.V., Parshin P.A., Vostroilova G.A. Parameters of Toxicity of the Complex Antimicrobial Drug Levoterasulfine Forte. Aktualnyye Problemy Bolezney Molodnyaka v Sovremennykh Usloviyakh = Actual Problems of Diseases of Young Animals in Modern Conditions. The Materials of the International Scientific and Practical Conference. Voronezh, September 23-25, 2002. Voronezh Publ., 2002. P. 11 (In Russ.).
11.Nieder C., Zimmermann F.B., Adam M., Molls M. The Role of Pentoxifylline as a Modifier of Radiation Therapy. Cancer Treatment Reviews. 2005;31:448-455.
12.Delanian S., Lefaix J. Current Management for Late Normal Tissue Injury: Radiation-Induced Fibrosis and Necrosis. Semin. Radiat. Oncol. 2007;17:99-107.
13.Boerma M., Roberto K.A., Hauer-Jensen M. Prevention and Treatment of Functional and Structural Radiation Injury in the Rat Heart by Pentoxifylline and Alpha-Tocopherol. Int. J. Radiol. Oncol. Biol. Phys. 2008;72;1:170-177.
14.Sezer A., Ustra U., Kosak Z., Yagci M.A. The Effect of Flavonoid Fractions Diosmin + Hesperidin on Radiation-Induced Acute Proctitis in Rat Model. J. Can. Res. Ther. 2011;7;2:152-156.
15.Jagetia G.C., Rao K.V.N.M. Topical Application of Hesperidin, a Citrus Bioflavonone Accelerates Healing of Full Thickness Dermal Excision Wounds of Mice Exposed to 6 Gy of Whole Body γ-Radiation. SM J. Nutr. Metab. 2017;3;2:1021.
16.Dion M.W., Hussey D.H., Osborne J.W. The Effect of Pentoxifylline on Early and Late Radiation Injury Following Fractionated Irradiation in C3H Mice. Int. J. Radiat. Oncol. Biol. Phys. 1989;17;1:101-107.
17.Olascoaga A., Vilar-Compte D., Poitevin-Chacon A., Contreras-Ruis J. Wound Healing in Radiation Skin Pathophysiology and Treatments Options. Int. Wound J. 2008;2008:2:246-257.
18.Kotenko K.V., Moroz B.B., Nasonova T.A., et al. Experimental model of severe local radiation injuries of the skin after x-rays. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya = Pathological Physiology and Experimental Therapy. 2013;57;4:121-123 (In Russ.).
19.Li Y., Kandhare A.D., Mukherjee A.A., Bodhankar S.L. Acute and Sub-Chronic Oral Toxicity Studies of Hesperidin Isolated from Orange Peel Extract in Sprague Dawley Rats. Regulary Toxicology and Pharmacology. 2019;105:77-85.
20.Meyer O.C. Safety and Security Daflon 500 mg in Venus Insufficiency and Hemorrhoidal Diseases. Angiology.1994;45;6(Suppl. 2):579-584.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.11.2022. Accepted for publication: 25.01.2023.